US FDA Announces OTC Monograph Drug User Fee Rates, Giving 45 Days For First Facility Payments

The FDA says the new OTC monograph drug user-fee program (OMUFA) will provide additional resources needed to support the streamlined regulatory activities described by OTC drug reform legislation enacted in March 2020.